
Protein protects against liver fibrosis
In mice, a team headed by Philipp Lang from University Düsseldorf, Germany, showed that the iRhom2 protein counteracted the injury- and...

Cell transdifferentiation specialist Mogrify Ltd raises US$16m
The company has developed a unique scalable technology for direct cellular transdifferentiation, based on the FANTOM5 dataset of human regulatory...

Cellectis presents way to safer CAR-Ts
The company presented the in vitro "proof-of-concept" of their new CAR-T cells, in which they integrated a gene network that senses tumour...

Research team improves safety of LGMD2A gene therapy
Limb-girdle muscular dystrophy type 2A (LGMD2A or LGMDR1) is a neuromuscular disorder hat causes progressive muscle weakness and has no cure. The...

Sanofi buys Synthorx Inc for US$2.35bn
Sanofi SA‘s and Synthorx Inc's Boards approved the deal which forsees that Sanofi will acquire all of the outstanding shares of Synthorx for $68 per...

EU with poor success in fighting superbugs
Although some progress has been made through EU action, there is little evidence so far to suggest that the health burden of antimicrobial resistance...